Status: current, Defined. Date: 31-Jan 2018. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2549971000168117 | Vyvanse (lisdexamfetamine dimesilate 40 mg) capsule, 30 capsules (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2549981000168119 | Vyvanse 40 mg capsule, 30 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Vyvanse 40 mg capsule, 30 | Is a | lisdexamfetamine dimesilate 40 mg capsule, 30 | true | Inferred relationship | Some | ||
| Vyvanse 40 mg capsule, 30 | Is a | trade product pack | true | Inferred relationship | Some | ||
| Vyvanse 40 mg capsule, 30 | has TPUU | Vyvanse 40 mg capsule | true | Inferred relationship | Some | 1 | |
| Vyvanse 40 mg capsule, 30 | has TP | Vyvanse | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Vyvanse 40 mg capsule, 30, bottle | Is a | True | Vyvanse 40 mg capsule, 30 | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR